1-232806098-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019090.3(MAP10):c.649C>A(p.Gln217Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019090.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP10 | NM_019090.3 | c.649C>A | p.Gln217Lys | missense_variant | 1/1 | ENST00000418460.4 | NP_061963.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP10 | ENST00000418460.4 | c.649C>A | p.Gln217Lys | missense_variant | 1/1 | NM_019090.3 | ENSP00000403208 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000558 AC: 85AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000141 AC: 35AN: 248924Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135152
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1461624Hom.: 0 Cov.: 35 AF XY: 0.0000426 AC XY: 31AN XY: 727090
GnomAD4 genome AF: 0.000558 AC: 85AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.1075C>A (p.Q359K) alteration is located in exon 1 (coding exon 1) of the MAP10 gene. This alteration results from a C to A substitution at nucleotide position 1075, causing the glutamine (Q) at amino acid position 359 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at